Nerve zap device shows promise for bladder and bowel woes

NCT ID NCT05064384

Completed Disease control Sponsor: Axonics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study looked at how well the Axonics sacral neuromodulation system works for people with bladder or bowel control problems. 272 participants were tracked to see if their symptoms improved and if the device was safe. The device uses mild electrical pulses to calm overactive nerves, aiming to reduce urgent leaks, frequent urination, and fecal incontinence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Axonics Sacral Neuromodulation System (implantable device)
What this could lead to: If successful, this could confirm that the Axonics device reliably reduces urgent leaks, frequent urination, and fecal incontinence, offering a long-term management option.
What could go wrong: This is a completed registry study, not a randomized trial, so results may be less definitive. Some participants may not respond or may experience device-related side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fecal Incontinence overactive bladder Urinary Incontinence, Urge Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FECAL INCONTINENCE URGENCY-FREQUENCY URINARY RETENTION URINARY URGE INCONTINENCE

Contacts and locations

Locations

Adult Pediatric Urology & Urogynecology

Omaha, Nebraska, 68114, United States
Arkansas Urology Research Center

Little Rock, Arkansas, 72210, United States
Center for Pelvic Health

Franklin, Tennessee, 37067, United States
Chesapeake Urology

Hanover, Maryland, 21076, United States
Comprehensive Urology

Royal Oak, Michigan, 48073, United States
Florida Urology Partners

North Redington Beach, Florida, 33708, United States
Florida Urology Partners

Tampa, Florida, 33606, United States
Institute for Female Pelvic Medicine and Reconstructive Surgery

Allentown, Pennsylvania, 18103, United States
LSU Health

New Orleans, Louisiana, 70112, United States
Manatee Medical Research Institute

Bradenton, Florida, 34205, United States
New Jersey Urology

Englewood, New Jersey, 07631, United States
Northwestern

Chicago, Illinois, 60611, United States
Ochsner Health

New Orleans, Louisiana, 70121, United States
Penn State University

Hershey, Pennsylvania, 17033, United States
Pinellas Urology

St. Petersburg, Florida, 33710, United States
Sansum Clinic Urology

Santa Barbara, California, 93105, United States
Southern Urogynecology

West Columbia, South Carolina, 29169, United States
Stanford Medicine

Redwood City, California, 94063, United States
Stony Brook University

Stony Brook, New York, 11794, United States
The Female Pelvic Health Center

Newtown, Pennsylvania, 33606, United States
The Urology Center PC

Omaha, Nebraska, 68114, United States
University of Alberta

Edmonton, Alberta, Canada
University of California, Irvine

Irvine, California, 92697, United States
University of Cincinnati

Cincinnati, Ohio, 45267-0558, United States
University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States
Urologic Solutions

Fort Myers, Florida, 33908, United States
Urologic Specialists Oklahoma

Tulsa, Oklahoma, 74146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.